Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

EPINASTINE HYDROCHLORIDE

EPINASTINE HYDROCHLORIDE

Standard Dose
0.05%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview EPINASTINE HYDROCHLORIDE is listed in Drugs@FDA under application 204055 (ANDA).

Marketing status: Discontinued Active ingredient EPINASTINE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.05% Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 2017-05-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview EPINASTINE HYDROCHLORIDE is listed in Drugs@FDA under application 204055 (ANDA). Marketing status: Discontinued Active ingredient EPINASTINE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.05% Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 2017-05-05 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.